DecisionNotesOveractiveBladder(OAB)SharedVerbiageIncompleteSLA andSLAComplianceNon-FormularyGridPARequiredand BvsDMAPDTransitionalOverrideBEERsListIncompleteNotesIncompleteMA-OnlyBronchospasmrelated toCOPDNF, ST,TCSE,QLMedicallyacceptedindicationStrength ofrecommendationis III andevidence isinconclusive orineffectiveUrgencyand casetypeStrength ofrecommendationis class I, IIa, IIbwith any efficacyor III if evidencefavor efficacyNot FDA-approvedDiagnosisReviewStep-TherapyPDPNon-FormularyDefaultduration -12/31/13DecisionNotesOveractiveBladder(OAB)SharedVerbiageIncompleteSLA andSLAComplianceNon-FormularyGridPARequiredand BvsDMAPDTransitionalOverrideBEERsListIncompleteNotesIncompleteMA-OnlyBronchospasmrelated toCOPDNF, ST,TCSE,QLMedicallyacceptedindicationStrength ofrecommendationis III andevidence isinconclusive orineffectiveUrgencyand casetypeStrength ofrecommendationis class I, IIa, IIbwith any efficacyor III if evidencefavor efficacyNot FDA-approvedDiagnosisReviewStep-TherapyPDPNon-FormularyDefaultduration -12/31/13

Medicare Overview/Incomplete/NF/ST/Off-Label - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Decision Notes
  2. Overactive Bladder (OAB)
  3. Shared Verbiage
  4. Incomplete SLA and SLA Compliance
  5. Non-Formulary Grid
  6. PA Required and BvsD
  7. MAPD
  8. Transitional Override
  9. BEERs List
  10. Incomplete Notes
  11. Incomplete
  12. MA-Only
  13. Bronchospasm related to COPD
  14. NF, ST, TCSE, QL
  15. Medically accepted indication
  16. Strength of recommendation is III and evidence is inconclusive or ineffective
  17. Urgency and case type
  18. Strength of recommendation is class I, IIa, IIb with any efficacy or III if evidence favor efficacy
  19. Not FDA-approved
  20. Diagnosis Review
  21. Step-Therapy
  22. PDP
  23. Non-Formulary
  24. Default duration - 12/31/13